Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Companies

IRulya Therapeutics Inc.

Biological Products, (No Diagnostic Substances)Nasdaq

Ticker IRLA. 13 dated commitments on record, 11 still open or being checked.

Execution profile

Commitments recorded
13
11 open
Clear outcomes
1
1 met · 0 late or partly · 0 not met or withdrawn
Delivered by the original date
1 of 1
rate shown from 15 outcomes
Commitments restated
0
no deadline pushed later
Targets reduced
0
wording weakened: 0
No public record found
1
never counted for or against

Separate measures of what IRulya Therapeutics Inc. said and what the public record showed, from 13 commitments. Every entry is listed below with its sources. How outcomes are decided

Kept Scores are not yet published

We are building the verified historical record first. Scores will be published once there is enough hand-checked history for them to mean something, and the methodology will be fixed and dated before the first score appears. This company has 0 commitments with a clear outcome in the last 3 years (the Kept Score window); the execution profile covers all years on record. How the score will work

IRulya Therapeutics Inc.'s complete recordEvery commitment, outcome and evidence link as a report and spreadsheet. Checked by a person, emailed within one business day · $49

Get the report · $49 Follow free by email

Coming due

Dated commitments IRulya Therapeutics Inc. announced whose deadlines fall in the next six months. After each deadline, and a 30-day allowance, we check what the public record shows.

  1. 31 Dec 2026Initiate Phase 2 clinical trial for SAPH
  2. 31 Dec 2026Initiate a Phase 2 study of LAM-001 in sarcoidosis-associated pulmonary hypertension (SAPH)
  3. 31 Mar 2027Report Phase 2 clinical trial data for BOS
  4. 31 Mar 2027Report Phase 2 data for LAM-001 in bronchiolitis obliterans syndrome (BOS)

Commitments

  • Deadline
  • Met
  • Late
  • Not met
  • Today

Get IRulya Therapeutics Inc.'s full record

Every commitment, outcome, evidence link and restatement as a report and spreadsheet, checked by a researcher against the SEC filings and emailed within one business day of payment.

Get the report · $49

Is this your company?

This page is public and free. Claim it to get a reminder before each deadline IRulya Therapeutics Inc. announced, add your own sources to any entry, and receive a quarterly summary compared with your sector.

Claim this page

Does something on this page need correcting? IRulya Therapeutics Inc. and any reader can ask us to check an entry, with a link to a public source.

Report an error Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.